Cargando…
Identification and validation of fusidic acid and flufenamic acid as inhibitors of SARS-CoV-2 replication using DrugSolver CavitomiX
In this work, we present DrugSolver CavitomiX, a novel computational pipeline for drug repurposing and identifying ligands and inhibitors of target enzymes. The pipeline is based on cavity point clouds representing physico-chemical properties of the cavity induced solely by the protein. To test the...
Autores principales: | Hetmann, M., Langner, C., Durmaz, V., Cespugli, M., Köchl, K., Krassnigg, A., Blaschitz, K., Groiss, S., Loibner, M., Ruau, D., Zatloukal, K., Gruber, K., Steinkellner, G., Gruber, C. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362000/ https://www.ncbi.nlm.nih.gov/pubmed/37479788 http://dx.doi.org/10.1038/s41598-023-39071-z |
Ejemplares similares
-
Recent changes in the mutational dynamics of the SARS-CoV-2 main protease substantiate the danger of emerging resistance to antiviral drugs
por: Parigger, Lena, et al.
Publicado: (2022) -
Structural bioinformatics analysis of SARS-CoV-2 variants reveals higher hACE2 receptor binding affinity for Omicron B.1.1.529 spike RBD compared to wild type reference
por: Durmaz, Vedat, et al.
Publicado: (2022) -
Optimizing variant-specific therapeutic SARS-CoV-2 decoys using deep-learning-guided molecular dynamics simulations
por: Köchl, Katharina, et al.
Publicado: (2023) -
Serine 477 plays a crucial role in the interaction of the SARS-CoV-2 spike protein with the human receptor ACE2
por: Singh, Amit, et al.
Publicado: (2021) -
Polymorphic transitions in flufenamic acid-trehalose composites
por: Pang, Yuying, et al.
Publicado: (2023)